Literature DB >> 12714863

Prevalence of the main cardiovascular risk factors in Morocco: results of a National Survey, 2000.

Mohammed A Tazi1, Saädia Abir-Khalil, Noureddine Chaouki, Sanaa Cherqaoui, Fatima Lahmouz, Jamal E Sraïri, Jaouad Mahjour.   

Abstract

OBJECTIVE: The aim of this study was to determine the prevalence of the main cardiovascular risk factors in Morocco and their distribution according to age, sex and residential area.
METHODS: The study was conducted during the year 2000 on a Moroccan representative sample aged 20 years and over, considering the population distribution between urban and rural areas. The crude results were weighted according to the Moroccan population distribution by age and sex. In order to allow comparison with data from other countries, means and prevalence were standardized according to world population distribution by age.
RESULTS: The participation rate was 90.1%. The prevalence of hypertension was 33.6% (30.2% for men and 37.0% for women). The means of systolic and diastolic blood pressure were 129.8 and 76.0 mmHg, respectively. The prevalence of diabetes was 6.6% and was similar for males and females. The prevalence of hypercholesterolaemia was 29.0%, and was higher in females. The means and prevalence of diabetes and hypercholesterolaemia were higher in urban areas. The prevalence of hypertension, diabetes and hypercholesterolaemia increased with age. The prevalence of obesity was markedly higher in females and in urban areas. The average body mass index was 23.8 and 25.6 kg/m2 in males and females, respectively. Thirty-four per cent of men smoked cigarettes, but women rarely smoked cigarettes (0.6%).
CONCLUSIONS: The prevalence of cardiovascular risk factors was high in Morocco and it is necessary to increase action against the cardiovascular diseases and their risk factors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12714863     DOI: 10.1097/00004872-200305000-00013

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  45 in total

1.  Prevalence, awareness, treatment, and control of hypertension among Arab Americans.

Authors:  Ayman Tailakh; Janet C Mentes; Donald E Morisky; Nancy A Pike; Linda R Phillips; Lorraine S Evangelista
Journal:  J Cardiovasc Nurs       Date:  2013 Jul-Aug       Impact factor: 2.083

2.  Metabolic syndrome and socioeconomic status in France: The French Nutrition and Health Survey (ENNS, 2006-2007).

Authors:  M Vernay; B Salanave; C de Peretti; C Druet; A Malon; V Deschamps; S Hercberg; K Castetbon
Journal:  Int J Public Health       Date:  2013-09-03       Impact factor: 3.380

Review 3.  Hypertension prevalence, awareness, and control in Arab countries: a systematic review.

Authors:  Ayman Tailakh; Lorraine S Evangelista; Janet C Mentes; Nancy A Pike; Linda R Phillips; Donald E Morisky
Journal:  Nurs Health Sci       Date:  2013-09-30       Impact factor: 1.857

4.  Maternal effect and familial aggregation in a type 2 diabetic Moroccan population.

Authors:  Houda Benrahma; Imen Arfa; Majida Charif; Safaa Bounaceur; Abdelmajid Eloualid; Redouane Boulouiz; Halima Nahili; Omar Abidi; Hassan Rouba; Asmaa Chadli; Mounia Oudghiri; Ahmed Farouqui; Sonia Abdelhak; Abdelhamid Barakat
Journal:  J Community Health       Date:  2011-12

5.  Control of blood pressure and cardiovascular risk in Moroccan patients with newly diagnosed hypertension: a 3-month observational study in primary care.

Authors:  Mohamed Alami; Mustapha El Hattaoui; Mehdi Seqat; Jamaa Sadik; Aicha Aouad; Mohammed Benghanem Gharbi
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-11-25

Review 6.  Dialysis-treated end-stage kidney disease in Libya: epidemiology and risk factors.

Authors:  Fathea Abobker Goleg; Norella Chiew-Tong Kong; Ramesh Sahathevan
Journal:  Int Urol Nephrol       Date:  2014-03-27       Impact factor: 2.370

7.  Effect of Peroxisome Proliferator-Activated Receptor-γ Coactivator-1 Alpha Variants on Spontaneous Clearance and Fibrosis Progression during Hepatitis C Virus Infection in Moroccan Patients.

Authors:  Raouia ElFihry; Mohcine Elmessaoudi-Idrissi; Fatima-Zahra Jadid; Imane Zaidane; Hajar Chihab; Mohamed Tahiri; Mostafa Kabine; Wafaa Badre; Isabelle Chemin; Agnes Marchio; Pascal Pineau; Sayeh Ezzikouri; Soumaya Benjelloun
Journal:  Virol Sin       Date:  2020-04-15       Impact factor: 4.327

8.  The Moroccan Genetic Disease Database (MGDD): a database for DNA variations related to inherited disorders and disease susceptibility.

Authors:  Hicham Charoute; Halima Nahili; Omar Abidi; Khalid Gabi; Hassan Rouba; Malika Fakiri; Abdelhamid Barakat
Journal:  Eur J Hum Genet       Date:  2013-07-17       Impact factor: 4.246

9.  Prevalence and demographic factors of smoking in Morocco.

Authors:  Chakib Nejjari; Mohamed Chakib Benjelloun; Mohamed Berraho; Karima El Rhazi; Nabil Tachfouti; Samira Elfakir; Zineb Serhier; Karen Slama
Journal:  Int J Public Health       Date:  2009-10-23       Impact factor: 3.380

10.  Ethnic differences in cardiometabolic risk profile in an overweight/obese paediatric cohort in the Netherlands: a cross-sectional study.

Authors:  Mariska van Vliet; Inès A von Rosenstiel; Roger K Schindhelm; Desiderius P M Brandjes; Jos H Beijnen; Michaela Diamant
Journal:  Cardiovasc Diabetol       Date:  2009-01-19       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.